Top Los Angeles, CA Biotech Companies (24)
Don't see your company?
Create a company profile.jpg)
Lightship is your complete solution for decentralized clinical trials. We built our virtual-first clinical trial model from the ground up, allowing patients to participate in clinical trials from the comfort of home. Come join the team perfecting the way clinical trials are done!
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+ consultants around the world through our Nextcontinent partnership, we work where you do to deliver the change you seek.
Beckman Coulter is committed to advancing healthcare for every person by applying the power of science, technology, and the passion and creativity of our teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. Our diagnostic systems are used in complex biomedical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. Beckman Coulter offers a unique combination of people, processes and solutions designed to elevate the performance of clinical laboratories and healthcare networks. We do this by accelerating care with a menu that matters, bringing the benefit of automation to all, delivering greater insights through clinical informatics and unlocking hidden value through performance partnership. An operating company of Danaher Corporation since 2011, Beckman Coulter is headquartered in Brea, Calif., and has more than 11,000 global associates working diligently to make the world a healthier place.
Seed Health is a microbial sciences company pioneering applications of microbes for human and planetary health. In collaboration with leading academic researchers, we advance breakthrough discoveries in microbial sciences across a pipeline of novel therapeutics, consumer health innovations and environmental solutions. All consumer innovations in probiotics are commercialized under Seed®.
Applied Invention is a multidisciplinary innovation company that designs, builds, and develops technology solutions in partnership with leading companies and entrepreneurs. We are an interdisciplinary group of engineers, scientists, and artists with skills in mathematics, physics, biology, electronics, mechanics, systems engineering, software development, and industrial design. Our projects range from computer vision, database software, data analytics, and high performance computing to biotechnology, medical devices, robotics, and generally complex systems. In 2014, Applied Invention was spun-off from Applied Minds, where the team started new companies including Applied Proteomics, Metaweb Technologies (acquired by Google), and TouchShare and developed technology solutions with partners such as Northrop Grumman, Herman Miller, Sun Microsystems, General Motors, and Intel. Applied Invention continues to advise and collaborate with leading entrepreneurs to create new technology solutions and companies. If you are a self-starter that shares our passion for solving problems that matter, for pushing the limits of what's possible, and for asking hard questions, we want to meet you.
Chemistry is the key to drug discovery, but chemical data is stuck in the twentieth century. We’re generating precise chemical datasets purpose-built to propel drug discovery into the information age — and we’re doing it on a larger scale and faster than has ever before been possible. Terray Therapeutics is a biotechnology company led by pioneers and long-time leaders in artificial intelligence, synthetic (medicinal) chemistry, biology and preclinical development, automation, and nanotechnology. Chemical datasets generated using our novel ultra-dense microarray technology work seamlessly with our integrated machine learning and computational platform to systematically map biochemical interactions between small molecules and causes of disease. Iterative cycles of virtual molecular design and experimentation power AI and machine learning models, which in turn guide the next cycle of design. With a chemistry engine that measures billions of interactions daily and becomes increasingly precise with every cycle, we can answer an unprecedented array of questions — deriving insights that enable us to predictably create drugs for patients in need.
AmpliPhi Biosciences is focused on developing novel bacteriophage-based therapeutics.
Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics.
ACELYRIN, INC. is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates and leveraging its expertise to rapidly advance these medicines to patients. ACELYRIN is embedding a corporate culture of Courageous Caring™—placing patients first and embracing the concept that all of us are better than any one of us. ACELYRIN addresses the most basic human needs—to live a productive life free from diseases.
ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex’s patent portfolio. ChromaDex delivers Niagen® as the sole active ingredient in its consumer product, Tru Niagen® — available at www.truniagen.com and through partnerships with global retailers and distributors. For company news, press releases, and more, visit www.chromadex.com. ChromaDex® is a publicly traded company (NASDAQ: CDXC).
Siragen Pharmaceuticals is an innovative biotechnology company.
Specializing in Microfluidic Product Development, ALine uses a rapid Design-Build-Test-Scale Cycle platform to help customers create commercially successful Microfluidics-based and Lab-on-a-Chip products. Throughout our 17 years in business, ALine’s expert engineering solutions allows our customers to move their product quickly from research and development to product transfer and large-scale manufacturing. ALine’s unique culture of scientific excellence and practical problem solving is realized in the quality and performance of every device we build. We’ve supported thousands of customers in building their microfluidic devices, let us help you!
Kernel creates the interfaces and insights necessary to unlock the greatest scientific unknown: the inner workings of the human brain and mind. Kernel is a full-stack neurotech company founded in 2016 with the mandate to do something that will change the world. Kernel is leveraging the best non-invasive brain scanning techniques to create next-generation technologies that dramatically expand the accuracy, frequency, and environments in which cognitive activity can be monitored. Our proprietary technology is designed in-house, and built from the ground up, with neuroscientists, physicists, and engineers controlling every step of the process, from chip design to optics; control software to machine learning; experimental design to analysis. Most noninvasive methods for recording brain signals measure electromagnetic fields generated by groups of neurons, or detect small changes in blood oxygenation (which correlate well to nearby neural activity). But existing technology in both of these technologies are rife with drawbacks, limitations or shortcomings. Kernel is building the next generation of both of these modalities, leveraging the strengths of OP-MEG (optically-pumped magnetoencephalography) and TD-fNIRS (time-domain functional near-infrared spectroscopy) into products that offer the following benefits: • High-quality neural signal • Full-head coverage • Scalability • Relatively low cost • Natural environments, stimuli, and interactions • Freedom of user motion
Spira creates carbon negative materials from genetically engineered algae grown by a global network of farming partners to produce ingredients for food, cosmetic and textile companies.
Ocular is an Anti- Money Laundering (AML) compliance platform that provides instant verification of a customer`s background (KYC). The platform leverages cryptographic security mechanisms employed in distributed ledger technologies to ensure that data cannot be tampered with, while allowing users full control over how their data is stored and shared. The system is user-friendly for applicants while adhering to strict AML policy guidelines. Ocular integrates traditional name and personal data background checks with state-of-the-art identity verification mechanisms such as facial and voice recognition. This safeguards against ID theft, false registrations, Sybil attacks and other attacks which compromise and circumvent compliance. Ocular uses advanced technologies such as artificial intelligence (AI) and machine learning to dynamically monitor and upgrade its capabilities and defenses in the face of an ever-changing landscape of cyber security. The objective of Ocular is to provide parties a transparent mechanism to verify and validate one another, to prevent fraud and expose fraudulent activities. Ocular aim to be the de-facto standard for multi purpose, highly customizable and configurable solutions that bridges traditional finance with crypto and satisfies compliance requirements at the highest possible levels. The Ocular solution is the fastest way to achieve full AML compliance for your customers!
Gather Labs is a High Complexity CLIA Lab and wellness boutique focused on sparking joy in the diagnostic experience. We offer same day resulting for all diagnostic tests.
Anivive is focused on reshaping pet healthcare by bringing together experts in software development, veterinary medicine, and clinical research to accelerate the development of novel therapeutics. Anivive. Smarter for pet health.
Aadi Bioscience Inc. (Aadi) is a biopharmaceutical company focused on precision therapies for genetically-defined cancers. We strive to unleash the potential of mTOR inhibition by employing precision medicine & nanoparticle technology to bring transformational therapies to cancer patients with mTOR pathway driver alterations. Our lead product has been FDA-approved for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors (PEComa). Our world class leadership team is comprised of industry veterans from top biotech companies who have proven track records of bringing novel cancer therapies to market. A science-first mindset and patient-centric approach is in our genes. With a growing pipeline of studies, we remain dedicated to developing products for cancers with mTOR pathway driver alterations. For more information, please visit: https://aadibio.com/
AgriProtein is leading a new industry called nutrient upcycling. Our mission is to close the loop in food production. We use our technology to leverage the natural capabilities of the black soldier fly; feeding its larvae existing organic waste to create a sustainable, natural protein for pets, livestock and fish. Our industrial-scale bioconversion process takes organic waste streams from food factories, supermarkets, farms and restaurants, and recycles these into valuable products including: an insect based complete protein (MagMeal™), a versatile, natural oil (MagOil™) and a rich residual soil conditioner (MagSoil™). AgriProtein has been developing its technology since 2008. In 2016, we opened the world’s first industrial scale insect facility in Cape Town, South Africa with the capacity to divert 100 tonnes of organic waste from landfill per day and produce over 2,000 tonnes of MagMeal™ per year. AgriProtein is a subsidiary of the Insect Technology Group.
Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group
Work Your Passion. Live Your Purpose.
